European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: Practical guidance for use in patients at very high cardiovascular risk

1. Landmesser, U.
2. Chapman, M.J.
3. Farnier, M.
4. Gencer, B.
5. Gielen, S.
6. Hovingh, G.K.
7. Lüscher, T.F.
8. Sinning, D.
9. Tokgözoǧlu, L.
10. Wiklund, O.
11. Zamorano, J.L.
12. Pinto, F.J.
13. Catapano, A.L.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1093/EURHEARTJ/EHW480 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus